Dr. Natalie Ann Krane, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 15700 Sw Greystone Ct, Beaverton, OR 97006 Phone: 503-494-8510 Fax: 503-494-4631 |
Dr. Colin Cave, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 |
Attilia Marie Sawyer, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 |
News Archive
A Worcester Polytechnic Institute research team has received a four-year, $1.4 million award from the National Institutes of Health to continue a groundbreaking study of arterial plaque. This research could lead to tools that will enable physicians to predict the likelihood of plaque rupture, which is responsible for most heart attacks and strokes.
Today, the U.S. Food and Drug Administration alerted parents, caregivers and health care providers to the safety risks that jewelry used for relieving teething pain pose for children.
Protea Biosciences, Inc., a leading developer of new technology for pharmaceutical research, announced today that the company, in partnership with Mayoly-Spindler, a European pharmaceutical company, has commenced a Phase I/IIA human clinical trial for a new recombinant Lipase.
Salix Pharmaceuticals, Ltd. today announced that the Company has acquired rights to Lumacan™ from Photocure, a Norwegian specialty pharmaceutical company. Lumacan is a novel agent designed to assist in the detection of precancerous and cancerous lesions in the colon.
SPINAL MODULATION, Inc., a privately held medical device company focused on developing devices to treat chronic pain, today announced that the results of its prospective, multicenter Dorsal Root Ganglion (DRG) Stimulation Clinical Trial will be presented by David Caraway, MD, PhD, Timothy Deer, MD and Robert Levy, MD, PhD at the 14th Annual North American Neuromodulation Society (NANS) meeting.
› Verified 1 days ago